1 completed, 1 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Terminated 1 |
Follow Carsten Bindslev-Jensen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Behandling af Boern Med Foedevareallergi Med Omalizumab (Xolair) Omalizumab, Placebo - Food Allergy | Phase 4 | Completed | Carsten Bindslev-Jensen | 20 | 2019-11-01 | 2023-12-05 |
| Protection From Food Induced Anaphylaxis by Reducing the Serum Level of Specific IgE (Protana). Omalizumab Injection - Food Allergy | Phase 4 | Terminated | Carsten Bindslev-Jensen | 7 | 2019-07-01 | 2023-12-11 |
Food Hypersensitivity (2) · Anaphylaxis (1)
Omalizumab (2)
Denmark (2)
Charlotte G. Moertz, ProfMDPhd (1) · Susanne Halken, Prof DM MD (1)
2017 (1)